Nivolumab versus chemotherapy in patients with advanced oesophageal squamous cell carcinoma refractory or intolerant to previous chemotherapy (ATTRACTION-3): a multicentre, randomised, open-label, phase 3 trial
Titel:
Nivolumab versus chemotherapy in patients with advanced oesophageal squamous cell carcinoma refractory or intolerant to previous chemotherapy (ATTRACTION-3): a multicentre, randomised, open-label, phase 3 trial
Auteur:
Kato, Ken Cho, Byoung Chul Takahashi, Masanobu Okada, Morihito Lin, Chen-Yuan Chin, Keisho Kadowaki, Shigenori Ahn, Myung-Ju Hamamoto, Yasuo Doki, Yuichiro Yen, Chueh-Chuan Kubota, Yutaro Kim, Sung-Bae Hsu, Chih-Hung Holtved, Eva Xynos, Ioannis Kodani, Mamoru Kitagawa, Yuko